Larimar Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$3.37

+0.30 (+9.77%)

As of Feb 8, 1:59 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 16 94%

Hold 1 6%

Sell 0 0%

Price Target

Analyst Price Target +590.5% upside

Low Target $16.60

Average Target $23.27

High Target $30.48

Current Price $3.37

Current
$3.37

Target
$23.27

$16.60 $23.27 avg $30.48

Scenario Analysis

Bear Case

$16.60

392.6%

Low target

Base Case

$23.27

+590.5%

Avg target

Bull Case

$30.48

+804.5%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$30.90

-89.1% from high

52-Week Low

$17.37

+-80.6% from low

Target vs 52W High

$23.27

-24.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%